Aero Lite, a simplified decentralized exchange by Dromos Labs, has out-earned all other DEXs on the Arc blockchain in trading fees just two weeks after its launch on September 16, 2026. Despite holding about 20% of Arc's DEX liquidity, Aero Lite has generated approximately $10,177 in fees from $25 million in trading volume, thanks to its use of Slipstream concentrated-liquidity pools that focus liquidity in active price ranges. Arc is a stablecoin-focused Layer-1 blockchain with gas fees paid in USDC, and Aero Lite operates without the vote-escrow system used by its parent protocol, instead returning most fees directly to liquidity providers. The full Aero protocol, merging Aerodrome and Velodrome, is set to launch on Arc and six other EVM chains on October 21, 2026, which will change fee distribution dynamics by involving locked token holders.
Aero Lite's recent performance as a decentralized exchange on the Arc blockchain provides context for cryptocurrency market activity. For readers following crypto markets, here is Pluang's snapshot as of Oct 02, 2026 02:41 WIB: Among 50 major cryptocurrencies priced on Pluang, 30 rose and 19 fell today. Notable price changes include XLM at Rp3.940 with a 1-day change of -2.52%, ONE at Rp40 with +2.43%, and ADA at Rp4.425 with +2.17%. Typical hold times range from 84 to 152 days, with varied Pluang order activity percentages.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...
